Stephen R Brady - Net Worth and Insider Trading
Stephen R Brady Net Worth
The estimated net worth of Stephen R Brady is at least $630,958 dollars as of 2024-08-24. Stephen R Brady is the EVP, Strategy & Finance of Immune Design Corp and owns about 96,599 shares of Immune Design Corp (IMDZ) stock worth over $565,104. Stephen R Brady is also the President and CEO of Tempest Therapeutics Inc and owns about 46,376 shares of Tempest Therapeutics Inc (TPST) stock worth over $65,854. Details can be seen in Stephen R Brady's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen R Brady has not made any transactions after 2024-07-03 and currently still holds the listed stock(s).
Transaction Summary of Stephen R Brady
Stephen R Brady Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen R Brady owns 2 companies in total, including Atreca Inc (BCEL) , and Tempest Therapeutics Inc (TPST) .
Click here to see the complete history of Stephen R Brady’s form 4 insider trades.
Insider Ownership Summary of Stephen R Brady
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BCEL | Atreca Inc | 2021-07-14 | director |
TPST | Tempest Therapeutics Inc | 2024-07-03 | director & Chief Executive Officer |
Stephen R Brady Latest Holdings Summary
Stephen R Brady currently owns a total of 2 stocks. Among these stocks, Stephen R Brady owns 96,599 shares of Immune Design Corp (IMDZ) as of January 7, 2019, with a value of $565,104 and a weighting of 89.56%. Stephen R Brady also owns 46,376 shares of Tempest Therapeutics Inc (TPST) as of July 3, 2024, with a value of $65,854 and a weighting of 10.44%.
Latest Holdings of Stephen R Brady
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IMDZ | Immune Design Corp | 2019-01-07 | 96,599 | 5.85 | 565,104 |
TPST | Tempest Therapeutics Inc | 2024-07-03 | 46,376 | 1.42 | 65,854 |
Holding Weightings of Stephen R Brady
Stephen R Brady Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen R Brady has made a total of 0 transactions in Immune Design Corp (IMDZ) over the past 5 years. The most-recent trade in Immune Design Corp is the sale of 5,516 shares on January 7, 2019, which brought Stephen R Brady around $8,715.
According to the SEC Form 4 filings, Stephen R Brady has made a total of 1 transactions in Tempest Therapeutics Inc (TPST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tempest Therapeutics Inc is the acquisition of 35,000 shares on July 3, 2024, which cost Stephen R Brady around $73,850.
Insider Trading History of Stephen R Brady
- 1
Stephen R Brady Trading Performance
GuruFocus tracks the stock performance after each of Stephen R Brady's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen R Brady is 6.4%. GuruFocus also compares Stephen R Brady's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen R Brady within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen R Brady's insider trading performs compared to the benchmark.
Performance of Stephen R Brady
Stephen R Brady Ownership Network
Ownership Network List of Stephen R Brady
Ownership Network Relation of Stephen R Brady
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Stephen R Brady Owned Company Details
What does Atreca Inc do?
Who are the key executives at Atreca Inc?
Stephen R Brady is the director of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .
Atreca Inc (BCEL) Insider Trades Summary
Over the past 18 months, Stephen R Brady made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.
Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atreca Inc Insider Transactions
Stephen R Brady Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen R Brady. You might contact Stephen R Brady via mailing address: C/o Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle Wa 98102.